SFX by Ex Libris Inc.

Title:	Tetrahydroquinoline sulfonamides as vasopressin 1b receptor anatgonists
Source:	Bioorganic & Medicinal Chemistry Letters [0960-894X] Scott, Jack yr:2009

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Russell, R. "In vitro and in vivo pharmacological characterisation of the potent and selective vasopressin V(1A) receptor antagonist 4-[4-(4-Chloro-phenyl)-5-[1,2,3]triazol-2-ylmethyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl-(3,5-difluoro-phenyl) methanone (PF-00738245)." European journal of pharmacology 670.2-3 (2011): 347-55.
description	2.	Lightman, Stafford L. "Effect of vasopressin 1b receptor blockade on the hypothalamic-pituitary-adrenal response of chronically stressed rats to a heterotypic stressor." The Journal of endocrinology 200.3 (2009): 285-291.
description	3.	Roach, Steven L L. "Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines." Bioorganic & medicinal chemistry letters 18.12 (2008): 3504-8.
description	4.	Hara, O. "Synthesis of 2,6-dimethyl-9-aryl-9-phosphabicyclo[3.3.1]nonanes: their application to asymmetric synthesis of chiral tetrahydroquinolines and relatives." Tetrahedron 63.27 (2007): 6170-6181.
description	5.	Perron, J. "Synthesis of substituted azepino[3,4-b]indole-1,5-diones." European journal of organic chemistry 22 (2004): 4606-4613.
description	6.	Sobocinska, M. "Analogues of Arginine Vasopressin Modified in Position 2 or 3 with Naphthylalanine: Selective Antagonists of Oxytocin In-vitro." Journal of Pharmacy and Pharmacology 52.9 (2000): 1105-1112.
description	7.	Tao, Y. "AIRE recruits multiple transcriptional components to specific genomic regions through tethering to nuclear matrix." Molecular immunology 43.4 (2006): 335-45.
description	8.	Nishida, A. "Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo." The Journal of pharmacology and experimental therapeutics 282.1: 725-731.
description	9.	BERNARDINI, R. "IN-VIVO AND IN-VITRO EFFECTS OF ARGININE-VASOPRESSIN RECEPTOR ANTAGONISTS ON THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN THE RAT." Neuroendocrinology 73.1 (1994): 503-508.
description	10.	Vo, Duc D. "Synthesis of new mixed phenol/heterocyclic derivatives and studies of their activity as inhibitors of Bax/Bcl-xL interaction." Tetrahedron 70.2 (2013): 301-311.
description	11.	Davies, S. "A diastereodivergent strategy for the asymmetric syntheses of (â)-martinellic acid and (â)-4-epi-martinellic acid." Tetrahedron 69.46 (2013): 9779-9803.
description	12.	Arizpe, A. "Stereodivergent Synthesis of Two Novel Î±-Aminophosphonic Acids Characterised by a cis-Fused Octahydroindole System." European journal of organic chemistry 16 (2011): 3074-3081.
description	13.	Craighead, M. "Characterization of a novel and selective V1B receptor antagonist." Prog Brain Res 170 (2008): 527-535.
description	14.	Ikawa, T. "Preparation and Regioselective Diels-Alder Reactions of Borylbenzynes: synthesis of Functionalized Arylboronates." Angewandte Chemie (International ed. in English) 49.32 (2010): 5563-5566.
description	15.	May, J. "Biomimetic approach to communesin B (a.k.a. nomofungin)." Tetrahedron letters 44.6 (2003): 1203-1205.
description	16.	Wilkinson, M. "Asymmetric synthesis of an aminomethyl morpholine via double allylic substitution." Tetrahedron letters; 46.28 (2005): 4773-4775.
description	17.	Lopez, F. "LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo." Endocrinology 149.5 (2008): 2080-2089.
description	18.	BALLOT, S. "Synthesis of new C60 based phosphines." Tetrahedron letters; 44.49 (2003): 8811-8814.
description	19.	Raggenbass, M. "Vasopressin- and oxytocin-induced activity in the central nervous system: electrophysiological studies using in-vitro systems." Progress in neurobiology 64.3: 307-326.
description	20.	Chan, W.Y. Y. "The role of oxytocin receptors and vasopressin V(1a) receptors in uterine contractions in rats: Implications for tocolytic therapy with oxytocin antagonists." American journal of obstetrics and gynecology 175.5 (1996): 1331-1335.